Get startedLog in
    Picture of Jupiter Bioscience logo

    JUPITER — Jupiter Bioscience Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Jupiter Bioscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    C2007
    March 31st
    2008
    March 31st
    2009
    March 31st
    2010
    March 31st
    2011
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Other Revenue
    Total Revenue1,2141,5571,7992,3273,314
    Cost of Revenue
    Gross Profit6779161,1401,5461,963
    Selling / General / Administrative Expenses
    Research And Development
    Depreciation and Amortization
    Total Operating Expenses9441,2121,4211,8362,731
    Operating Profit271345378491583
    Net Income Before Taxes271345378491583
    Provision for Income Taxes
    Net Income After Taxes202297330425514
    Net Income Before Extraordinary Items
    Net Income202297330425514
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income202297330425514
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS20.519.719.723.27.96
    Dividends per Share